Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes
Keywords:single-day Famciclovir, genital herpes, patient-initiated episodic therapy
AbstractOne common method for treating recurrent genital herpes outbreaks is 3-5 day episodic therapy with nucleoside analogues. However, since maximum viral replication occurs within 24 h after the onset of symptoms, short-term patient-initiated episodic therapy started at prodromal onset or at the first appearance of lesions in patients without a prodrome may represent an important option. In a recent randomized trial, single-day Famciclovir treatment decreased lesion healing time and the duration of pain and other symptoms by approximately 2 days compared to placebo, and prevented progression to a full outbreak in almost one in four patients.
- ACOG Committee on Practice Bulletins – Gynecology (2004) Obstet Gynecol 104(5 pt 1):1111-1118.
- Aoki FY, Tyring S, Mitoma-Diaz F, Gross G, Gao J, Hamed K (2006) Single-day, patientinitiated famciclovir therapy for recurrent genital herpes: a randomized, double blind, placebo-controlled trial. Clin Infect Dis 42:8-13.
- Brown ZA, Kern ER, Spruance SL, Overall JC Jr (1979) Clinical and virologic course of herpes simplex genitalis. West J Med 130:414-421.
- Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T et al. (2004) Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350:11-20.
- Diaz-Mitoma F, Sibbald G, Shafran SD, Boon R, Saltzman RL (1998) Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. JAMA 280:887-892.
- Drob S, Loemer M, Lifshutz H (1985) Genital herpes: the psychological consequences. Br J Med Psychol 58 (Pt 4):307315.
- Fleming DT, McQuillan GM, Johnson RE et al. (1997) Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med 337:1105-1111.
- Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20:73-83.
- Leone PA, Trottier S, Miller JM (2002) Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 34:958-962.
- Malkin JE (2004) Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 11(suppl 1):2A-23A.
- Pue MA, Benet MA (1993) Pharmacokinetics of famciclovir in man. Antivir Chem Chemother 4(suppl 1):47-55.
- Reichman RC, Badger GJ, Guinan ME, Nahmias AJ, Keeney RE, Davis LG et al. (1983) Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis 147:336-340.
- Reichman RC, Badger GJ, Mertz GJ, Corey L, Richman DD, Connor JD et al. (1984) Treatment of recurrent genital her-pes simplex infections with oral acyclovir. A controlled trial. JAMA 251:2103-2107.
- Reitano M, Tyring S, Lang W, Thoming C, Worm AM, Borelli S et al. (1998) Valaciclovir for the suppression of recurent genital herpes simplex virus infection: a large-scale dose range-Wnding study. J Infect Dis 178:603-610.
- Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD (1996) Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. JAMA 276:44-49.
- Spruance SL (1995) Herpes simplex labialis. In: Sacks SL, Straus SE, Whitley RJ, et al. (eds). Clinical management of herpes viruses. IOS Press, Amsterdam, pp 3-42.
- Spruance SL, Wenerstrom G (1984) Pathogenesis of recur-rent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment. Oral Surg Oral Med Oral Pathol 58:667-671.
- Tyring SK, Douglas JM Jr, Corey L, Spruance SL, Esmann J (1998) A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir In ternational Study Group. Arch Dermatol 134:185-191.
- Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L (2002) Two-day regimen of acyclovir for treatment of re curent genital herpes simplex virus type 2 infection. Clin In fect Dis 34:944-948.
- Whitley RJ, Kimberlin DW, Roizman B (1998) Herpes simplex viruses. Clin Infect Dis 26:541-55.
How to Cite
Copyright (c) 2014 Стівен Тайєрін, Камал Хамед, Гарі Річвалд
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.